tiprankstipranks
Trending News
More News >
Solid Biosciences (SLDB)
NASDAQ:SLDB
US Market

Solid Biosciences (SLDB) Income Statement

Compare
1,582 Followers

Solid Biosciences Income Statement

Last quarter (Q4 2025), Solid Biosciences's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Solid Biosciences's net income was $-49.79M. See Solid Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 8.09M$ 13.62M
Gross Profit
$ -1.64M$ -2.46M$ -2.58M$ 8.09M$ 13.62M
Operating Expenses
$ 177.57M$ 127.27M$ 101.73M$ 114.55M$ 85.87M
Depreciation and Amortization
$ 1.64M$ 2.46M$ 2.58M$ 2.41M$ 2.96M
EBITDA
$ -179.21M$ -121.90M$ -93.43M$ -96.87M$ -69.29M
Operating Income
$ -179.21M$ -129.73M$ -104.31M$ -106.45M$ -72.25M
Other Income/Expenses
$ 4.88M$ 5.03M$ 8.30M$ 20.47M$ 66.00K
Pretax Income
$ -174.32M$ -124.70M$ -96.02M$ -85.98M$ -72.19M
Net Income
$ -174.32M$ -124.70M$ -96.02M$ -85.98M$ -72.19M
Per Share Metrics
Basic EPS
$ -1.99$ -3.06$ -4.83$ -10.10$ -10.14
Diluted EPS
$ -1.99$ -3.06$ -4.83$ -10.10$ -10.14
Weighted Average Shares Outstanding
87.50M 40.82M 19.88M 8.51M 7.12M
Weighted Average Shares Outstanding (Diluted)
87.50M 40.82M 19.88M 8.51M 7.12M
Currency in USD

Solid Biosciences Earnings and Revenue History